Long-term Semaglutide Leads to Continued Weight Loss Versus Placebo

A glucagon-like peptide 1 (GLP-1) receptor agonist, the therapy has been associated with weight loss, which is believed to be due to appetite control.

from Google Alert - How to lose weight https://ift.tt/2PMSUlT